Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
5.15
-0.19 (-3.56%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $164.36 million as of October 31, 2024. Its market cap has increased by 30.65% in one year.
Market Cap
164.36M
Enterprise Value
-17.92M
1-Year Change
30.65%
Ranking
Category
Stock Price
$5.15
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $164.36M, a decrease of -53.68%. That is a compound annual growth rate of -44.71%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 30, 2024 | 171.90M | 38.52% |
Dec 29, 2023 | 124.10M | -65.02% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Fulcrum Therapeutics | 202.18M |
Zentalis Pharmaceuticals | 201.24M |
Cabaletta Bio | 200.28M |
Corbus Pharmaceuticals Holdings | 196.80M |
Kodiak Sciences | 195.78M |
Vaxart | 189.93M |
MediWound | 189.52M |
LifeMD | 189.29M |